News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Staff September 11, 2023 Post Navigation Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) More Stories Healthcare News HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference Staff December 23, 2024 Clinical Trial News Pharmaceutical Glaukos Submits New Drug Application to U.S. FDA for Epioxa™ Staff December 23, 2024 Cancer News Pharmaceutical The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids Staff December 23, 2024
